Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-25

Clinical Trial Update: Evaluation of a Dietary Supplement Containing Melissa Officinalis Formulated in Phospholipids on Mood Well-being and Cortisol Modulation [NA]

View source ↗

Summary

A clinical trial evaluating a Melissa officinalis (lemon balm) dietary supplement formulated in phospholipids for mood well-being and cortisol modulation; curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melissa officinalis dietary supplement (phospholipid formulation) (Melissa officinalis extract)

Snippet

Sponsor: Azienda di Servizi alla Persona di Pavia | Conditions: Stress, Mood Disorders | NA | Status: NOT_YET_RECRUITING